Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
PACS Group, Inc.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-38.9% vs price
Base Case (Median)
-9.6% vs price
Bull Case (75th pct.)
42.8% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $71.60 | 68.5% | High (40%) |
| PE Comparable | $38.40 | -9.7% | Medium (25%) |
| Growth Trajectory DCF | $85.55 | 101.3% | Medium (20%) |
| Graham Number | $15.18 | -64.3% | Medium (40%) |
| EV/EBITDA | $2.24 | -94.7% | Medium (20%) |
| EV/FCF | $36.77 | -13.5% | Medium (20%) |
| Earnings Power Value | $49.80 | 17.2% | Medium (50%) |
Based on 7 out of 7 methods, PACS appears fairly valued at the current price of $42.50. The base case fair value of $38.40 implies 9.6% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.